These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 27806968)

  • 21. Primary care-based surveillance to estimate the proportion of rotavirus gastroenteritis among Latvian children below 5 years of age with acute gastroenteritis.
    Tafalla M; Gardovska D; Gopala K; Kozlovska L
    Hum Vaccin Immunother; 2019; 15(6):1272-1278. PubMed ID: 30335570
    [No Abstract]   [Full Text] [Related]  

  • 22. Analyses of health outcomes from the 5 sites participating in the Africa and Asia clinical efficacy trials of the oral pentavalent rotavirus vaccine.
    Breiman RF; Zaman K; Armah G; Sow SO; Anh DD; Victor JC; Hille D; Ciarlet M; Neuzil KM
    Vaccine; 2012 Apr; 30 Suppl 1():A24-9. PubMed ID: 22520132
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rotavirus strain surveillance for three years following the introduction of rotavirus vaccine into Belém, Brazil.
    Guerra SF; Linhares AC; Mascarenhas JD; Oliveira A; Justino MC; Soares LS; Müller EC; Brasil P; Tuboi S; Ortega-Barria E; Colindres R
    J Med Virol; 2015 Aug; 87(8):1303-10. PubMed ID: 25879653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term surveillance of rotavirus vaccination after implementation of a national immunization program in Finland (2008-2018).
    Hemming-Harlo M; Gylling A; Herse F; Haavisto I; Nuutinen M; Pasternack M; Kanibir MN; Hartwig S; Carias C
    Vaccine; 2022 Jun; 40(29):3942-3947. PubMed ID: 35641360
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of the rotavirus vaccine program across age groups in the United States: analysis of national claims data, 2001-2016.
    Baker JM; Dahl RM; Cubilo J; Parashar UD; Lopman BA
    BMC Infect Dis; 2019 Feb; 19(1):186. PubMed ID: 30795739
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rotavirus gastroenteritis hospitalizations in provinces with different vaccination coverage rates in Spain, 2013-2018.
    Ruiz-Contreras J; Alfayate-Miguelez S; Carazo-Gallego B; Onís E; Díaz-Munilla L; Mendizabal M; Méndez Hernández M; Ferrer-Lorente B; Unsaín-Mancisidor M; Ramos-Amador JT; Croche-Santander B; Centeno Malfaz F; Rodríguez-Suárez J; Cotarelo M; San-Martín M; Arístegui J
    BMC Infect Dis; 2021 Nov; 21(1):1138. PubMed ID: 34742235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of rotavirus vaccine in reducing hospitalization rates in pediatric patients: a single center experience in Italy.
    Dettori S; Cortesia I; Mariani M; Opisso A; Mesini A; Saffioti C; Castagnola E
    Hum Vaccin Immunother; 2021 Dec; 17(12):5646-5649. PubMed ID: 34766869
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduction in rotavirus-associated acute gastroenteritis following introduction of rotavirus vaccine into Australia's National Childhood vaccine schedule.
    Buttery JP; Lambert SB; Grimwood K; Nissen MD; Field EJ; Macartney KK; Akikusa JD; Kelly JJ; Kirkwood CD
    Pediatr Infect Dis J; 2011 Jan; 30(1 Suppl):S25-9. PubMed ID: 21183837
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The changes of the epidemiology and clinical characteristics of rotavirus gastroenteritis-associated convulsion after the introduction of rotavirus vaccine.
    Kawase M; Hoshina T; Yoneda T; Kojiro M; Takahashi Y; Kusuhara K
    J Infect Chemother; 2020 Mar; 26(3):206-210. PubMed ID: 31563335
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Socioeconomic Impact of the Rotavirus Vaccine in Korea: Comparing the Epidemiologic and Economic Characteristics of Rotavirus Gastroenteritis Before and After the Introduction of Vaccines.
    Cho H; Lee H; Kim DS; Kim HM; Kim JH; Kim AY; Kang HY
    Pediatr Infect Dis J; 2020 May; 39(5):460-465. PubMed ID: 31990891
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of rotavirus vaccination in Australian children below 5 years of age: a database study.
    Pendleton A; Galic M; Clarke C; Ng SP; Ledesma E; Ramakrishnan G; Liu Y
    Hum Vaccin Immunother; 2013 Aug; 9(8):1617-25. PubMed ID: 23733041
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Burden of paediatric rotavirus gastroenteritis and potential benefits of a universal rotavirus vaccination programme with RotaTeq in France.
    Huet F; Largeron N; Trichard M; Miadi-Fargier H; Jasso-Mosqueda G
    Vaccine; 2007 Aug; 25(34):6348-58. PubMed ID: 17629598
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in vaccine coverage and incidence of acute gastroenteritis and severe rotavirus gastroenteritis in children <5 years in Shibata City, Niigata Prefecture, Japan.
    Oishi T; Hasegawa S; Nakano T; Sudo S; Kuwajima H; Tokuriki S; Tamura T
    Hum Vaccin Immunother; 2024 Dec; 20(1):2322202. PubMed ID: 38478958
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The economic impact of the introduction of universal rotavirus vaccination on rotavirus gastroenteritis related hospitalisations in children in Ireland.
    Murphy A; Kirby A; De Blasio F
    Vaccine; 2023 Apr; 41(16):2656-2663. PubMed ID: 36948981
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hospitalised rotavirus gastroenteritis in New Zealand: The laboratory database is a valuable tool for assessing the impact of rotavirus vaccination.
    Kelly MJ; Foley D; Blackmore TK
    Vaccine; 2017 Aug; 35(35 Pt B):4578-4582. PubMed ID: 28720280
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute gastroenteritis hospitalizations after implementation of universal mass vaccination against rotavirus.
    Kõivumägi K; Toompere K; Soeorg H; Kallas E; Jõgeda EL; Huik K; ; Lutsar I
    Vaccine; 2020 Mar; 38(13):2879-2886. PubMed ID: 32067818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A population based study comparing changes in rotavirus burden on the Island of Ireland between a highly vaccinated population and an unvaccinated population.
    Armstrong G; Gallagher N; Cabrey P; Graham AM; McKeown PJ; Jackson S; Dallat M; Smithson RD
    Vaccine; 2016 Sep; 34(39):4718-4723. PubMed ID: 27527819
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sustained reduction in rotavirus-coded hospitalizations in children aged <5 years after introduction of self-financed rotavirus vaccines in Japan.
    Kobayashi M; Miyazaki M; Ogawa A; Tatsumi M
    Hum Vaccin Immunother; 2020; 16(1):132-137. PubMed ID: 31298962
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The occurrence of severe rotavirus gastroenteritis in children under 3 years of age before and after the introduction of rotavirus vaccine: a prospective observational study in three pediatric clinics in Shibata City, Niigata Prefecture, Japan.
    Oishi T; Taguchi T; Nakano T; Sudo S; Kuwajima H;
    Jpn J Infect Dis; 2014; 67(4):304-6. PubMed ID: 25056079
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decrease of Rotavirus Gastroenteritis to a Low Level Without Resurgence for Five Years After Universal RotaTeq Vaccination in Finland.
    Hemming-Harlo M; Markkula J; Huhti L; Salminen M; Vesikari T
    Pediatr Infect Dis J; 2016 Dec; 35(12):1304-1308. PubMed ID: 27455440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.